Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots

By sjmartinez • February 27, 2023

Weld ED, Parsons TL, Gollings R, McCauley M, Grinsztejn B, Landovitz RJ, Marzinke MA. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots. J Pharm Biomed Anal. 2023 Feb 17;228:115307. doi: 10.1016/j.jpba.2023.115307. Epub ahead of print. PMID: 36842333.

Tags: Cabotegravir, DBS, HIV, Infectious Diseases, LC-MS, Mass spectrometry, Publications, Rilpivirine

A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response

Gu Y, Singh S, Alqarihi A, Alkhazraji S, Gebremariam T, Youssef EG, Liu H, Fan X, Jiang WR, Andes D, Cochrane TR, Schwartz JA, Filler[...]

Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction tool

Swinnerton K, Fillmore NR, Vo A, La J, Elbers D, Brophy M, Do NV, Monach PA, Branch-Elliman W. Leveraging near-real-time patient and population data to[...]

Variability of antimicrobial susceptibility of commensal Neisseria species supports its use as a marker of excessive antimicrobial consumption – reflections from the results of a four-country study

Kanesaka I, Foschi C, Marangoni A, Adamson PC, Klausner J, Dong HV, Vanbaelen T, De Baetselier I, de Block T, Manoharan-Basil SS, Kenyon C. Variability[...]